<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="28440">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01932216</url>
  </required_header>
  <id_info>
    <org_study_id>ISI-RCTSS-001</org_study_id>
    <nct_id>NCT01932216</nct_id>
  </id_info>
  <brief_title>Cosmesis, Patient Satisfaction and Quality of Life After da Vinci Single Site and Multiport Laparoscopic Cholecystectomy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intuitive Surgical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Intuitive Surgical</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, randomized , multicenter study  comparing cholecystectomy performed with da
      Vinci Single Site Instruments™ to  multi-port (four ports) laparoscopy
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2013</start_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Cosmesis</measure>
    <time_frame>up to 3 months after surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>The primary objective of this study is to evaluate cosmesis, patient satisfaction and quality of life after robotic- assisted single incision cholecystectomy procedure using da Vinci Single- Site Instruments™ in comparison to a multiport laparoscopic approach.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">154</enrollment>
  <condition>Symptomatic Gallbladder Disease</condition>
  <arm_group>
    <arm_group_label>robotic single-site cholecystectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patient in this arm will undergo robotic single-site cholecystectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laparoscopic multi-port cholecystectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient in this arm will undergo Laparoscopic multi-port cholecystectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>robotic single-site  cholecystectomy</intervention_name>
    <arm_group_label>robotic single-site cholecystectomy</arm_group_label>
    <other_name>da Vinci Single-Site™ Instrumentation for the da Vinci® Si™ System</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laparoscopic multiport cholecystectomy</intervention_name>
    <arm_group_label>Laparoscopic multi-port cholecystectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient between ages of 18- 80 year

          -  Patient with symptomatic gallbladder disease

          -  Patient willing to participate in this study and able to provide informed consent

        Exclusion Criteria:

          -  Patient pregnancy

          -  Emergency patient

          -  Patient with  acute cholecystitis

          -  Patient with upper midline visible abdominal scars or keloid

          -  Presence of umbilical hernia , or prior umbilical hernia repair

          -  Inability of patients to tolerate Trendelenberg position or  pneumoperitoneum

          -  Patient with cirrhosis

          -  Patients with mental impairment that preclude giving informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 29, 2013</lastchanged_date>
  <firstreceived_date>August 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>robotic single-site cholecystectomy</keyword>
  <keyword>laparoscopic cholecystectomy</keyword>
  <keyword>cosmesis</keyword>
  <keyword>quality of life</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gallbladder Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
